|Articles|October 13, 2004
Contrast business prepares for shake-up
Advertisement
Bracco has invested in Chinese facilities to produce and ship contrast media. The investments are being made through a joint venture with Shanghai-based Sine Pharmaceutical. The Bracco-Sine production plant opened in June in Shanghai's high-tech district. It will focus on the final cycle in contrast media production. Chinese workers will formulate drug solutions from basic ingredients sent from Italy, then prepare, seal, and sterilize individual doses.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Leading Breast Radiologists Discuss the Recent Lancet Study on AI and Interval Breast Cancer
2
Is AI Better Than Neuroradiologists at Evaluating Aneurysm Growth on CTA and MRA Scans?
3
FDA Clears AI-Powered Triage Platform for Digital Breast Tomosynthesis
4
Study Shows Photon-Counting CT Reduces Radiation Exposure by 66 Percent for Patients with Lung Cancer
5








